Partner with a trusted team to guide your drug development pathway.
Our experienced consultants draw on a wealth of knowledge across a wide range of oncology indications to identify and deliver a development pathway for your therapy. We will customize a panel of Key Opinion Leaders based on your science and mechanism of action.
- Key Opinion Leader selection
- Meeting coordination and discussion preparation
- 2-4 hours of moderated discussion
- Detailed blueprint development and summary
- Dedicated Project Management
Advantage to your Program
Expert Panel discussions are ideal for emerging Biotech and small Pharma. They enable an immediate, strategic process for kickstarting your drug development planning.
TD2’s Regulatory Affairs Team engages Oncology drug development experts and strategists with proven track records of success. We leverage experienced, oncology-focused medical writers, regulatory experts in CMC, pharmacology, and toxicology, as well as regulatory program managers to provide a customized approach across all areas of drug development.